Eupraxia Pharmaceuticals Inc.

TSX:EPRX.TO

4.1 (CAD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CAD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Operating Activities:
Net Income -6.064-8.15-4.351-11.572-7.827-4.96-9.083-4.795-6.28-3.76-3.777-5.135-5.595-8.862-0.14-0.728-0.99-2.153-0.713
Depreciation & Amortization 0.0420.050.0080.050.0490.0490.0550.050.0490.0390.0410.030.020.020.0220.0210.0220.0520.053
Deferred Income Tax 00-1.962.738-0.05-0.0950.038-0.297-0.1130.0670.04-0.170.0621.273-0.062-0.0410.0720.042-0.025
Stock Based Compensation 1.4750.213-0.0720.4820.6850.3170.9560.160.2720.5260.5460.430.5282.7110.060.060.060.0480.15
Change In Working Capital -2.8450.3375.5620.3921.292-1.8932.268-1.2942.11-1.011-0.6622.0750.248-1.872-0.5230.430.1091.544-0.792
Accounts Receivables 0.0190.023-0-0.0240.0490.0030.271-0.0140.061-0.007-0.327-0.062000000-1.246
Change In Inventory 0000000000000000000
Change In Accounts Payables 0000000000000000000
Other Working Capital -2.8630.3140.0070.4151.243-1.8961.997-1.282.049-1.003-0.3352.1370000000.454
Other Non Cash Items -3.147-0.414-0.065-0.0370.8430.7350.4790.190.2380.2530.260.120.5653.6280.47-0.1280.3461.0130.251
Operating Cash Flow -10.539-8.254-0.879-7.947-5.693-6.164-5.287-5.88-3.725-3.884-3.553-2.481-4.234-4.374-0.11-0.346-0.4520.504-1.051
Investing Activities:
Investments In Property Plant And Equipment -0.011-0.009-0.041-0.013-0.009-0.011-0.085-0.051-0.166-0.007-0.018-0.408-0.001-0.00400000
Acquisitions Net 0000000000000000000
Purchases Of Investments 000000180-180-900000000
Sales Maturities Of Investments 0000000.0509.0090000000000
Other Investing Activites 0.029000000.023000-8.9960.0410-5.064000-0.022-0.097
Investing Cash Flow 0.018-0.009-0.041-0.013-0.009-0.01117.915-0.051-9.156-0.007-9.014-0.367-0.001-5.06700.0020.044-0.022-0.097
Financing Activities:
Debt Repayment -4.499-0.0280-0.027-0.026-0.03600-0.023-0.036-0.0780.4219.2792.0040-0.0070-0.730
Common Stock Issued 0.23222.8530.04815.8396.060.3080.074-0.59710.3200-0.8530.54130.00700000
Common Stock Repurchased 0000000000000000000
Dividends Paid 0000000000000000000
Other Financing Activities -1.3828.3990.1410.228-0.0220.2990.288-0.0472.956-0.009-0.048-0.022-0.5630-0.1690.0070.578-0.3051.1
Financing Cash Flow -5.88131.225-7.29422.0366.0120.260.362-0.04713.252-0.045-0.1480.3999.25740.407-0.169-0.0010.578-1.0351.1
Other Information:
Effect Of Forex Changes On Cash -0.398-0.4610.8180.039-0.080.045-0.0570.3890.141-0.075-0.060.04-0.06200-0.003000
Net Change In Cash -12.59115.382-13.86814.1140.247-5.88812.932-5.5890.512-4.011-12.775-2.4094.9630.966-0.279-0.3480.173-0.553-0.047
Cash At End Of Period 31.90548.59219.34233.2119.09618.84824.73611.80417.39216.88120.89233.66736.07631.1160.150.4290.7770.6041.156